AXIM Biotechnologies's total assets for Q2 2025 were $3.22M, a decrease of -3.65% from the previous quarter. AXIM total liabilities were $13.65M for the fiscal quarter, a -2.38% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.